HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yutaro Hayashi Selected Research

Tamsulosin (Flomax)

1/2012Tamsulosin reduces nighttime urine production in benign prostatic hyperplasia patients with nocturnal polyuria: a prospective open-label long-term study using frequency-volume chart.
10/2011Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yutaro Hayashi Research Topics

Disease

17Cryptorchidism (Undescended Testes)
03/2022 - 12/2005
15Hypospadias
12/2019 - 02/2002
8Urinary Tract Infections (Urinary Tract Infection)
03/2022 - 01/2010
8Neoplasms (Cancer)
01/2020 - 06/2003
6Vesico-Ureteral Reflux (Vesicoureteral Reflux)
04/2021 - 01/2010
6Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
10/2012 - 03/2008
5Prostatic Neoplasms (Prostate Cancer)
12/2019 - 03/2002
4Hydronephrosis
11/2020 - 04/2003
4Neoplasm Metastasis (Metastasis)
01/2020 - 06/2003
4Urolithiasis
10/2015 - 01/2005
3Spermatic Cord Torsion (Testicular Torsion)
01/2024 - 02/2012
3Urinary Retention
03/2023 - 12/2009
3Lower Urinary Tract Symptoms
03/2023 - 10/2009
3Ureterocele
01/2023 - 11/2006
3Calculi (Calculus)
10/2015 - 02/2007
2Fever (Fevers)
03/2023 - 11/2019
2Immunoglobulin G4-Related Disease
01/2023 - 06/2016
2Infarction (Infarctions)
01/2023 - 07/2012
2Hematuria
09/2022 - 11/2019
2Pain (Aches)
09/2022 - 01/2021
2Constipation
02/2021 - 06/2020
2Infections
01/2021 - 10/2002
2Rheumatoid Arthritis
08/2020 - 01/2020
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 01/2000
2Inguinal Hernia (Direct Inguinal Hernia)
11/2017 - 04/2011
2Testicular Neoplasms (Testicular Cancer)
05/2017 - 01/2007
2Azoospermia
05/2017 - 06/2006
2Renal Cell Carcinoma (Grawitz Tumor)
01/2017 - 04/2005
2Shock
11/2013 - 11/2006
2Inflammation (Inflammations)
01/2013 - 12/2010
2Seminoma
07/2012 - 01/2007
2Wilms Tumor (Wilm's Tumor)
05/2012 - 07/2010
2Kidney Calculi (Kidney Stone)
04/2012 - 06/2007
2Cicatrix (Scar)
01/2010 - 12/2002
2Hyperplasia
10/2009 - 09/2007
1Prolapse
01/2023
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2023
1Epididymitis
01/2023
1Ureteral Calculi
09/2022
1Infertility (Sterility)
03/2022
1Liposarcoma
01/2022
1Carcinoma (Carcinomatosis)
07/2021
1Disease Progression
04/2021
1Meningomyelocele (Myelomeningocele)
02/2021
1Overactive Urinary Bladder (Overactive Bladder)
02/2021
1Neural Tube Defects (Exencephaly)
02/2021
1Neurogenic Urinary Bladder (Bladder, Neurogenic)
02/2021

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
12/2017 - 03/2002
5Hormones (Hormone)IBA
03/2022 - 03/2002
5Messenger RNA (mRNA)IBA
02/2018 - 06/2006
4Transcription Factors (Transcription Factor)IBA
04/2014 - 06/2006
3CreatinineIBA
09/2022 - 12/2002
3Cisplatin (Platino)FDA LinkGeneric
01/2013 - 03/2002
2cyclic citrullinated peptideIBA
08/2020 - 01/2020
2Endocrine DisruptorsIBA
12/2019 - 08/2010
2Anti-Bacterial Agents (Antibiotics)IBA
11/2019 - 01/2010
2Cytochrome P-450 CYP1A1 (CYP1A1)IBA
02/2018 - 07/2012
2Immunoglobulin G (IgG)IBA
06/2016 - 09/2006
2Androgen Receptors (Androgen Receptor)IBA
11/2014 - 03/2002
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2014 - 10/2011
2Tamsulosin (Flomax)FDA LinkGeneric
01/2012 - 10/2011
2bisphenol AIBA
01/2012 - 01/2012
2Estrogens (Estrogen)FDA Link
01/2011 - 08/2010
2AndrogensIBA
01/2011 - 08/2008
2Estrogen Receptor alphaIBA
01/2011 - 08/2010
2naftopidilIBA
10/2009 - 09/2007
2Flutamide (Eulexin)FDA LinkGeneric
01/2007 - 03/2002
2TeaIBA
08/2005 - 01/2005
2Calcium OxalateIBA
08/2005 - 01/2005
2LigandsIBA
04/2005 - 06/2003
2AntigensIBA
04/2005 - 06/2003
2Indicators and Reagents (Reagents)IBA
04/2005 - 03/2002
2Cell Adhesion MoleculesIBA
04/2005 - 06/2003
2E-SelectinIBA
04/2005 - 06/2003
2NF-kappa B (NF-kB)IBA
06/2003 - 03/2002
1tocilizumab (atlizumab)FDA Link
01/2023
1inhibin BIBA
03/2022
1Cholinergic Antagonists (Anticholinergics)IBA
02/2021
1N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA
02/2021
1propiverineIBA
02/2021

Therapy/Procedure

11Therapeutics
04/2021 - 03/2002
8Orchiectomy (Orchidectomy)
01/2024 - 01/2007
8Orchiopexy
01/2024 - 12/2005
8Nephrectomy
01/2017 - 07/2007
7Replantation
01/2023 - 08/2012
4Drug Therapy (Chemotherapy)
01/2020 - 01/2007
3Nephroureterectomy
07/2021 - 04/2006
3Castration
12/2019 - 01/2009
3Radiotherapy
01/2016 - 03/2008
3Operative Surgical Procedures
07/2008 - 02/2002
2Conservative Treatment
01/2023 - 11/2020
2Antibiotic Prophylaxis
06/2020 - 01/2010
2Cystectomy
01/2020 - 01/2013
2Operative Time
02/2014 - 08/2012
2Lithotripsy (Extracorporeal Shockwave Lithotripsy)
11/2013 - 11/2006
2Prostatectomy (Retropubic Prostatectomy)
08/2013 - 03/2008
2Adjuvant Chemotherapy
01/2013 - 07/2010
2Surgical Flaps
06/2007 - 05/2003
1Catheters
03/2023
1Transurethral Resection of Prostate (TURP)
03/2023